Literature DB >> 3922529

Onchocerciasis now.

D Bell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3922529      PMCID： PMC1415664          DOI： 10.1136/bmj.290.6480.1450

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  7 in total

1.  Ivermectin in onchocerciasis.

Authors:  K Awadzi; K Y Dadzie; H Schulz-Key; D R Haddock; H M Gilles; M A Aziz
Journal:  Lancet       Date:  1984-10-20       Impact factor: 79.321

2.  Efficacy and tolerance of ivermectin in human onchocerciasis.

Authors:  M A Aziz; S Diallo; I M Diop; M Lariviere; M Porta
Journal:  Lancet       Date:  1982-07-24       Impact factor: 79.321

3.  The chemotherapy of onchocerciasis VII. The effect of prednisone on the Mazzotti reaction.

Authors:  K Awadzi; M L Orme; A M Breckenridge; H M Gilles
Journal:  Ann Trop Med Parasitol       Date:  1982-06

4.  The chemotherapy of onchocerciasis VI. The effect of indomethacin and cyproheptadine on the Mazzotti reaction.

Authors:  K Awadzi; M L Orme; A M Breckenridge; H M Gilles
Journal:  Ann Trop Med Parasitol       Date:  1982-06

5.  22, 23--dihydroavermectin B1, a new broad-spectrum antiparasitic agent.

Authors:  J R Egerton; J Birnbaum; L S Blair; J C Chabala; J Conroy; M H Fisher; H Mrozik; D A Ostlind; C A Wilkins; W C Campbell
Journal:  Br Vet J       Date:  1980 Jan-Feb

6.  Chemotherapy of onchocerciasis: a controlled comparison of mebendazole, levamisole, and diethylcarbamazine.

Authors:  A R Rivas-Alcalá; B M Greene; H R Taylor; A Domíguez-Vázquez; A M Ruvalcaba-Macías; C Lugo-Pfeiffer; C D Mackenzie; F Beltrán
Journal:  Lancet       Date:  1981-09-05       Impact factor: 79.321

7.  The chemotherapy of onchocerciasis iii. A comparative study of diethylcarbamazide (DEC) and metrifonate.

Authors:  K Awadzi; H M Gilles
Journal:  Ann Trop Med Parasitol       Date:  1980-04
  7 in total
  1 in total

1.  Immunopathology of ocular onchocerciasis. I. Inflammatory cells infiltrating the anterior segment.

Authors:  C C Chan; E A Ottesen; K Awadzi; R Badu; R B Nussenblatt
Journal:  Clin Exp Immunol       Date:  1989-09       Impact factor: 4.330
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.